Comparing two drugs for bleeding ulcers
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether a newer drug, tegoprazan, works as well as the standard drug lansoprazole for healing bleeding ulcers in the stomach or small intestine. You will get one of these drugs for 14 days and have a follow-up endoscopy to check healing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a bleeding ulcer in your stomach or small intestine, confirmed by a scope exam.
- You agree to stay in the hospital for IV acid-reducing medicine for 3 days, have a scope within 24 hours, and take the study pill for 14 days.
- You are willing to have another scope after 14 days to see how the ulcer is healing.
- You are not allergic to tegoprazan or lansoprazole.
- You do not have advanced kidney disease or severe liver cirrhosis, and you are not a heavy drinker or taking certain medications like chemotherapy or bisphosphonates.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two acid-reducing medicines—Tegoprazan and Lansoprazole—to see which works better for stopping bleeding from a peptic ulcer. If you have a confirmed upper GI bleed from an ulcer, this study may help find the best treatment for you.
This study tests a new medicine to help heal stomach ulcers. It may be an option if you have a stomach ulcer that is not too large and is at a certain stage of healing.
This study compares two acid-reducing medications, keverprazan and pantoprazole, to see which is better at stopping bleeding from the upper digestive tract (stomach or food pipe). If you have had bleeding in your stomach or intestines, this trial could help determine the most effective treatment for you.
This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.
This trial compares two different types of stomach-acid-lowering medicines — tegoprazan and a proton pump inhibitor (PPI) — to see which works better at clearing H. pylori infection. It's for people who have not been treated for H. pylori before and can safely have a stomach scope.
This study compares two treatments that reduce stomach acid after a bleeding ulcer has been repaired with an endoscope. It aims to find which one is better at preventing the ulcer from bleeding again.
Hear when a new Peptic Ulcer Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.